Form 10-Q · Quarterly report

Procter & Gamble 10-Q, filed Oct 22, 2026

Filed
CIK
0000080424
Accession no.
0000080424-26-000256
AI-generated summary

Summary

Procter & Gamble reported net sales of $23.3 billion for the quarter ended September 30, 2026, up 4.0% from a year earlier, with diluted EPS of $1.97 and core EPS of $2.00, and on October 1, 2026 completed its $3.9 billion all-cash acquisition of wellness and supplement brand Thorne. The company is also executing a portfolio and productivity plan announced in June 2025, expected to cost about $2.0 billion in before-tax restructuring charges over two years, including a reduction of up to 7,000 non-manufacturing overhead positions by the end of fiscal 2027.

Key points

  • Net sales rose 4.0% to $23.3 billion, driven by a 2.4% unit volume increase, 1.1% favorable geographic mix and 0.4% higher pricing.
  • Gross margin fell 160 basis points to 49.8% of net sales, and net earnings attributable to Procter & Gamble were $4.73 billion.
  • Operating cash flow was $5.8 billion and free cash flow $4.4 billion, a 93% free cash flow productivity rate.
  • Thorne, which primarily sells in North America, will be part of the Personal Health Care segment and its results will be reported from the quarter ending December 31, 2026.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

From the filing

Item 2. Management's Discussion OVERVIEW P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in about 180 countries and territories, primarily through mass merchandisers, e-commerce (including social commerce) channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to individual consumers. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Procter & Gamble in Readster

Add Procter & Gamble to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.